TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP)(“Nanobac” or “the Company”) announces that scientists from the University of California San Francisco, collaborating with Nanobac scientists at NASA’s Johnson Space Center, have concluded research demonstrating that calcium deposits in the human kidney called Randall’s Plaque may in fact be Calcifying Nano Particles (CNPs, also referred to as nanobacteria) which lead to the formation of Kidney Stones.
